◆ Latest: Retatrutide Phase 3 trial reports 24% weight reduction at 48 wks◆ Established: 10 peptides now FDA approved for metabolic indications◆ Preclinical: BPC-157 meta-analysis (17 rodent studies) published◆ Evidence: new mitochondrial peptide review covers MOTS-c, SS-31, Humanin◆ Safety: hCG supply disruption update, Q2 2026◆ Editorial: The Mitochondrial Decade, new long-read◆ Latest: Retatrutide Phase 3 trial reports 24% weight reduction at 48 wks◆ Established: 10 peptides now FDA approved for metabolic indications◆ Preclinical: BPC-157 meta-analysis (17 rodent studies) published◆ Evidence: new mitochondrial peptide review covers MOTS-c, SS-31, Humanin◆ Safety: hCG supply disruption update, Q2 2026◆ Editorial: The Mitochondrial Decade, new long-read

Definition

IM (Intramuscular)

Administration via injection directly into muscle tissue, allowing faster absorption than SubQ. Common sites include deltoid, thigh, and glute.

Browse the full glossary

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.